139 related articles for article (PubMed ID: 35151689)
41. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
42. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
43. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
Hiraga R; Kato M; Miyagawa S; Kamata T
Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
[TBL] [Abstract][Full Text] [Related]
44. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
[TBL] [Abstract][Full Text] [Related]
45. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
[TBL] [Abstract][Full Text] [Related]
46. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
47. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
48. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma.
Dardare J; Witz A; Merlin JL; Gilson P; Harlé A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429474
[TBL] [Abstract][Full Text] [Related]
49. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
50. TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.
Chow JY; Ban M; Wu HL; Nguyen F; Huang M; Chung H; Dong H; Carethers JM
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G275-82. PubMed ID: 19940030
[TBL] [Abstract][Full Text] [Related]
51. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
Jung DE; Kim JM; Kim C; Song SY
Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
[TBL] [Abstract][Full Text] [Related]
52. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
53. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB
Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993
[TBL] [Abstract][Full Text] [Related]
54. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Rowland-Goldsmith MA; Maruyama H; Matsuda K; Idezawa T; Ralli M; Ralli S; Korc M
Mol Cancer Ther; 2002 Jan; 1(3):161-7. PubMed ID: 12467210
[TBL] [Abstract][Full Text] [Related]
55. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.
Shichi Y; Sasaki N; Michishita M; Hasegawa F; Matsuda Y; Arai T; Gomi F; Aida J; Takubo K; Toyoda M; Yoshimura H; Takahashi K; Ishiwata T
Sci Rep; 2019 Jul; 9(1):10871. PubMed ID: 31350453
[TBL] [Abstract][Full Text] [Related]
56. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma.
Lee HK; Nam MW; Go RE; Koo J; Kim TH; Park JE; Choi KC
Biomed Pharmacother; 2023 Mar; 159():114212. PubMed ID: 36610224
[TBL] [Abstract][Full Text] [Related]
57. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
[TBL] [Abstract][Full Text] [Related]
58. Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Wagatsuma T; Nagai-Okatani C; Matsuda A; Masugi Y; Imaoka M; Yamazaki K; Sakamoto M; Kuno A
Front Oncol; 2020; 10():338. PubMed ID: 32232009
[TBL] [Abstract][Full Text] [Related]
59. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
60. Alteration of Transforming Growth Factor β Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma.
Li M; Li A; Zhao X; Hou S; Lu S; Mou Y; Liu X; Cai S; Cao D; Tian B
Pancreas; 2020 Apr; 49(4):534-542. PubMed ID: 32282767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
